Migraine with Aura and Stroke Risk: What to Know

Yes, migraine with aura is associated with approximately twice the risk of ischemic stroke compared to no migraine. The absolute risk remains low for most patients — we are not talking about a condition that puts you on the same footing as someone who has already had a TIA — but the connection is real, well-documented, and clinically important. It matters especially for women, smokers, and people using combined hormonal contraceptives, where the risks compound in ways that change the conversation about contraception, lifestyle, and prevention.

This article draws on peer-reviewed research from three neurologists in the Convene network who have helped define what we know about migraine biology and its population-level burden. Peter Goadsby at UCLA has published foundational work on how the trigeminovascular system drives migraine [1][2]. Richard Lipton at Montefiore has contributed landmark data on how many Americans have migraine and what it costs them [3][4]. David Borsook, formerly of Harvard and Boston Children's Hospital, has written about the deeper neurobiological model of migraine as a disorder of stress response and allostatic load [5][6].

What is migraine aura?

Aura refers to the reversible neurological symptoms — most often visual, but sometimes sensory or involving speech — that occur in the 20 to 60 minutes before or during a migraine headache. The visual form is the most common: a shimmering arc or zigzag line that slowly expands across part of the visual field, often with a blind spot at its center. Sensory aura typically causes tingling or numbness that spreads from the fingertips up the arm and across the face. Speech aura is rarer and involves difficulty finding or producing words, which can be frightening to experience for the first time.

The underlying mechanism is cortical spreading depression, a slowly moving wave of neuronal depolarization that travels across the surface of the brain, typically starting in the visual cortex at the back of the head. As the wave propagates, it temporarily suppresses normal neuronal activity in its wake — which is what creates the visual disturbance. Research summarized in Goadsby's 2017 Physiological Reviews analysis of migraine pathophysiology lays out how this wave of electrical dysfunction then triggers the trigeminal pain pathways that produce the headache [1]. The aura itself is not dangerous for most people. The concern is what the brain may be doing at a vascular level during and after that wave.

What the research shows about stroke risk

Multiple large meta-analyses have examined the relationship between migraine with aura and ischemic stroke, and the finding has held up consistently: people with migraine with aura have roughly twice the relative risk of ischemic stroke compared to people without migraine. The elevation is specific to the aura subtype — migraine without aura shows a much smaller or no reliable signal.

The risk is most pronounced in women under 45, a group already at lower baseline stroke risk, which makes the relative doubling more clinically relevant. Data from the American Migraine Study II, published in Headache in 2001, showed that approximately 27.9 million Americans had migraine at the time — about 18 percent of women and 6 percent of men [3]. A 2021 Lancet review on migraine epidemiology and systems of care confirmed that the cardiovascular risk signal tied to migraine with aura has been replicated in prospective cohorts and is considered robust enough to inform clinical guidelines [4].

To be precise about the absolute numbers: for a healthy woman in her 30s without other risk factors, the annual risk of ischemic stroke is already quite low, around 3 to 8 per 100,000 person-years. Doubling that is still a small number. But when you add other risk factors — combined oral contraceptives, smoking, hypertension — the arithmetic changes.

Why the connection exists

The exact mechanism linking aura to stroke risk is still under active investigation, but several pathways have emerged from the literature.

Cortical spreading depression, the wave that produces aura symptoms, does not just cause electrical changes. It also transiently reduces cerebral blood flow in a phenomenon called spreading oligemia — a period where blood supply to the affected cortex falls below normal levels. Goadsby's trigeminovascular work showed that CGRP and other vasoactive peptides are released during this process [2], and there is evidence that prolonged oligemia could, in theory, create conditions that favor infarction in vulnerable tissue.

Platelet activation is a second mechanism. During migraine attacks, platelets become more sticky and aggregate more readily — a state associated with increased clotting risk. The 2015 Journal of Neuroscience paper from Borsook and colleagues described migraine as a disorder involving multiple interacting processes, including neuroinflammatory and vascular components [5], and the allostatic load framework elaborated in Borsook's 2012 Neuron paper positions chronic migraine as a state of persistent physiological dysregulation that likely affects vascular function over time [6].

Patent foramen ovale — a small opening between the upper chambers of the heart that fails to close after birth — is found at higher rates in people with migraine with aura, and there is some evidence of a bidirectional relationship. Small emboli passing through a patent foramen ovale may trigger aura in susceptible individuals, which could explain part of the stroke association. This remains an area of active research.

Who has the highest risk

The groups where the stroke-migraine with aura association becomes clinically urgent are well-defined.

Women with migraine with aura who use combined estrogen-progestin oral contraceptives face a compounding risk. Estrogen independently elevates clotting risk, and the combination with migraine with aura raises stroke risk substantially — by some estimates four- to eightfold compared to women who have neither. This is not a theoretical concern; it is the basis for international contraceptive guidelines.

Smoking adds further risk. Migraine with aura plus smoking has been shown to multiply stroke risk beyond what either factor does alone. The biology is consistent with what we know about smoking's effects on endothelial function and platelet behavior.

Hypertension is a classic stroke risk factor and interacts with migraine with aura in the same way it interacts with any state of increased vascular vulnerability. Age-related accumulation of other cardiovascular risk factors — diabetes, hyperlipidemia — matters too.

Family history of early ischemic stroke in a first-degree relative, particularly in women, is a reason to be more alert about risk stratification.

What this means practically

The most concrete clinical implication is the contraindication on combined estrogen-containing hormonal contraceptives — the pill, the patch, and the vaginal ring — for women who have migraine with aura. This is reflected in World Health Organization medical eligibility criteria as a Category 4 restriction, meaning the risks outweigh the benefits. The key distinction: progestin-only methods (the mini-pill, hormonal IUD, the implant, the shot) are not subject to this restriction. If you have migraine with aura and are on a combined pill, that is the most urgent conversation to have with your gynecologist or prescriber.

Migraine treatment itself does not raise stroke risk. Triptans, which are widely used for acute migraine and work by constricting certain blood vessels, are often raised as a concern, but the available evidence does not show that triptan use elevates stroke risk at the doses used clinically. Preventive medications like beta-blockers, certain antiepileptics, and CGRP monoclonal antibodies have no known prothrombotic effect.

Migraine without aura and stroke

The stroke signal in migraine without aura is far weaker and inconsistent across studies. Some meta-analyses find a modest elevation in relative risk, others find none. For the large majority of the roughly 28 million Americans with migraine — most of whom have migraine without aura — this is reassuring. The specific biology of cortical spreading depression appears to be what drives the association, and without aura, that mechanism is not consistently present.

When to see a neurologist immediately

Seek emergency evaluation for any of the following:

• A neurological symptom during aura that lasts longer than 60 minutes without resolving
• Weakness or paralysis on one side of the body during what seems like an aura
• The first or worst headache of your life, especially if it comes on suddenly like a thunderclap
• Headache accompanied by fever, stiff neck, or confusion
• Sudden painless vision loss or double vision

These presentations are not typical migraine and require urgent assessment to rule out stroke, hemorrhage, or other serious causes.

Managing risk proactively

The most evidence-backed way to reduce stroke risk in someone with migraine with aura is to control the modifiable risk factors that amplify it. That means:

• Reviewing contraceptive choice with your prescribing physician if you use combined hormonal methods
• Quitting smoking, which removes a compounding vascular risk factor
• Keeping blood pressure in a normal range — migraine patients should know their numbers
• Treating migraine preventively if attacks are frequent, since a lower attack frequency means less exposure to whatever vascular mechanisms are activated during aura
• Having at least an annual blood pressure check, given that hypertension is often asymptomatic and interacts badly with migraine

Migraine prevention — whether with CGRP inhibitors, beta-blockers, or other evidence-based agents — is primarily aimed at reducing headache frequency and improving quality of life, not at stroke prevention specifically. But fewer attacks means less overall physiological burden, which is consistent with Borsook's allostatic load model of what chronic migraine does to the nervous system over time [6].

Questions to ask your neurologist

• Do I have migraine with aura, or migraine without aura, and how confident are you in that classification?
• Given my specific risk factors — age, contraceptive use, blood pressure, smoking history — what is my actual stroke risk in practical terms?
• Should I switch from a combined hormonal contraceptive to a progestin-only or non-hormonal method?
• Is my migraine frequency high enough that preventive treatment would reduce whatever vascular exposure comes with frequent attacks?
• Are there any symptoms during my aura that should prompt me to call 911 rather than wait it out?

The bottom line

Migraine with aura is a real but modest independent risk factor for ischemic stroke — approximately a doubling of relative risk, which translates to a small absolute number for most healthy adults. The risk becomes clinically meaningful in women who also smoke or use combined estrogen-containing contraceptives, where the factors stack. Switching to a progestin-only or non-hormonal contraceptive and addressing modifiable cardiovascular risk factors are the most actionable responses. If you have migraine with aura and have not had a conversation about stroke risk with a neurologist or your primary care physician, that conversation is worth having.